Drozapol-Profil Statistics
Total Valuation
Drozapol-Profil has a market cap or net worth of PLN 25.02 million. The enterprise value is 20.09 million.
| Market Cap | 25.02M |
| Enterprise Value | 20.09M |
Important Dates
The last earnings date was Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Drozapol-Profil has 6.12 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 6.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 64.28% |
| Owned by Institutions (%) | n/a |
| Float | 2.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.40 |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | 3.04 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.00 |
| EV / Sales | 0.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.44 |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.62 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.13 |
| Interest Coverage | -7.98 |
Financial Efficiency
Return on equity (ROE) is -5.74% and return on invested capital (ROIC) is -4.25%.
| Return on Equity (ROE) | -5.74% |
| Return on Assets (ROA) | -3.56% |
| Return on Invested Capital (ROIC) | -4.25% |
| Return on Capital Employed (ROCE) | -6.71% |
| Revenue Per Employee | 1.46M |
| Profits Per Employee | -93,349 |
| Employee Count | 43 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 3.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.30% in the last 52 weeks. The beta is 0.83, so Drozapol-Profil's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -9.30% |
| 50-Day Moving Average | 3.63 |
| 200-Day Moving Average | 3.84 |
| Relative Strength Index (RSI) | 65.99 |
| Average Volume (20 Days) | 9,460 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Drozapol-Profil had revenue of PLN 62.79 million and -4.01 million in losses. Loss per share was -0.66.
| Revenue | 62.79M |
| Gross Profit | 1.67M |
| Operating Income | -4.86M |
| Pretax Income | -2.39M |
| Net Income | -4.01M |
| EBITDA | -4.16M |
| EBIT | -4.86M |
| Loss Per Share | -0.66 |
Balance Sheet
The company has 5.96 million in cash and 1.06 million in debt, giving a net cash position of 4.90 million or 0.80 per share.
| Cash & Cash Equivalents | 5.96M |
| Total Debt | 1.06M |
| Net Cash | 4.90M |
| Net Cash Per Share | 0.80 |
| Equity (Book Value) | 66.34M |
| Book Value Per Share | 10.85 |
| Working Capital | 31.02M |
Cash Flow
In the last 12 months, operating cash flow was 8.33 million and capital expenditures -88,000, giving a free cash flow of 8.24 million.
| Operating Cash Flow | 8.33M |
| Capital Expenditures | -88,000 |
| Free Cash Flow | 8.24M |
| FCF Per Share | 1.35 |
Margins
Gross margin is 2.66%, with operating and profit margins of -7.74% and -6.39%.
| Gross Margin | 2.66% |
| Operating Margin | -7.74% |
| Pretax Margin | -3.81% |
| Profit Margin | -6.39% |
| EBITDA Margin | -6.62% |
| EBIT Margin | -7.74% |
| FCF Margin | 13.12% |
Dividends & Yields
Drozapol-Profil does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -16.04% |
| FCF Yield | 32.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 19, 2014. It was a reverse split with a ratio of 0.2.
| Last Split Date | Nov 19, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
Drozapol-Profil has an Altman Z-Score of 2.13. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.13 |
| Piotroski F-Score | n/a |